🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

JULELÆSNING: Få læger får en stilling, der er delt mellem klinik og forskning. 34-årige Lars Wiuff Andersen er en af dem. Forskning i international klasse kan godt lade sig gøre alligevel, for lægerne forsker i deres fritid. Men er det rimeligt? #sundpol buff.ly/3V6LOFl

New results, EMPIRE HF - by PhD student Julie Hempel; ▶️ The effect of empagliflozin (10mg/d/12w) on cardiac structure and function vs placebo - NOT affected by background treatment with angiotensin receptor-neprilysin inhibitor RigsHeart 🫀🚨 Herlev og Gentofte hosp afd for hjertesygdomme sciencedirect.com/science/articl…

& discussion w/ Drs. Emil Wolsk (Herlev og Gentofte hosp afd for hjertesygdomme), Henrik Wiggers (Department of Cardiology Research AUH) & RN Camilla Thomassen (OUH). Multifactorial disease surveillance by #MDT? #GP, #HF_clinic, #dyspnoea_clinic? Søren Lund Kristensen Finn Gustafsson #DCS_HF2023 Jannik Pallisgaard @kr_johanna

Teaming up again with #Borlaugslab. This paper highlights the hemodynamic differences in #HFpEF with #LVEF > 65%. We should rethink some aspects in future HFpEF trials. Alessio Alogna Yogesh Reddy Dan Burkhoff MD PhD Mayo Clinic CV Research Unit of Cardiology, OUH HFAPresident

Well deserved award 🍾🍾

Our 💙❤️ beat for the Empire Prevent Trial in both Odense Research Unit of Cardiology, OUH and Copenhagen Herlev og Gentofte hosp afd for hjertesygdomme. So proud to be working with the team: Camilla Fuchs Andersen, morten schou and Jacob Eifer Møller🫀🫀

Next yrs Danish HF meeting will be in Aarhus -and my tenure as organizer has come to an end after 6 yrs, Thx to co-organizers morten schou, Finn Gustafsson, Lars Køber, Lærke Nelson, Jawad Haider Butt MD, Anne-Christine Ruwald, Edina Hadžiselimović, MD, PhD 💜👩🏻‍⚕️🩺🎶🇩🇰, Julie Vishram-Nielsen, Massar, Dansk Cardiologisk Selskab (DCS) and pharma for support!

What would you do? Low output heart failure (what CCU literature would call cardiogenic shock) with severe pulm HTN and severe MR on echo, EF 20%, max tolerated GDMT, low CO 2.4 L/min (CI 1.6). Despite severe MR mean PCWP only 24, but mean PA 57, PVR 14.

Promising preliminary findings in this experimental study! Results from the STEP #HFpEF: once-weekly #semaglutide in people with HFpEF and #obesity, will be presented at the #ESC conference 25. August!

#SGLT2i's benefit in #HFpEF, but why and how? First in HFpEF! SGLT2i's effect on #PCWP by #RHC in a mechanistic randomized trial. #Dapa⬇️PCWP, improving the fundamental hemodynamic abnormality underlying HFpEF. Circulation Mayo Clinic Yogesh Reddy #Borlaugslab ahajournals.org/doi/10.1161/CI…

While waiting for #heartfailure data from SELECT a glimpse of potential benefit in PPL with #obesity with HFpEF from STEP HFpEF with 2.4mg semaglutide #heartdisease novonordisk.com/content/dam/nn…

Ready, steady, go 💪🏻 #ESCCongress 2023 Massar Julie Hempel

Every minute of this epic United Nations address from State of Palestine is worth watching. She dismantles Israel's lies and disinformation, sets out what Palestine stands for, and why it will succeed. Watch and Share! #Gaza_War #Gaza_Genocide

This Mayo Clinic study on 476 #HFpEF patients reveals crucial insights: Only 26% had no atrial #myopathy, while 31% had isolated LA myopathy, 39% biatrial, and 4% isolated right atrial (RA). Biatrial myopathy linked to worse outcomes: more #AFib , left and right ventricular

The effect of #SGLT2i on left cardiac remodelling in #HFrEF: Systematic review and meta-analysis onlinelibrary.wiley.com/doi/full/10.10… European Society of Cardiology Journals

The DanGerShock trial - a significant reduction of mortality with the use of the Impella device in cardiogenic shock patients 🫀! NEJM @Abiomed RigsHeart 🫀🚨 Christian Hassager JacobEMoller PCRonline 🫀

The Research Strategy Group met to shape the 2026-2030 strategy for OUH Odense Svendborg @kliniskinstitut, where I participated on focusing on global collaboration and research excellence. Grateful for a great team and insightful discussions.